Development of a TB vaccine trial site in Africa and lessons from the Ebola experience

Development of a TB vaccine trial site in Africa and lessons from the Ebola experience

Abstract Tuberculosis is the deadliest infection of our time. In contrast, about 11,000 people died of Ebola between 2014 and 2016. Despite this manifest difference in mortality, there is now a vaccine licensed in the United States and by the European Medicines Agency, with up to 100% efficacy again...

Full description

Bibliographic Details
Main Authors: G. Kaguthi, V. Nduba, P. Rabuogi, D. Okelloh, S. G. Ouma, G. Blatner, S. Gelderbloem, Ellen M. H. Mitchell, Cherise P. Scott, S. Verver, T. Hawkridge, J. E. M. de Steenwinkel, K. F. Laserson, J. H. Richardus
Format: Article
Language:English
Published: BMC 2020-06-01
Series:BMC Public Health
Subjects:
Vaccines
Ebola
Tuberculosis
Trials
Sites
Emerging infectious diseases
Online Access:http://link.springer.com/article/10.1186/s12889-020-09051-3

Internet

http://link.springer.com/article/10.1186/s12889-020-09051-3

Similar Items